METE, A. Ö. Et Al. 2024. Safety Evaluation and Tolerability Overview of Favipiravir in the Management of COVID-19: A Real-Life Experience from Turkey. İstanbul Medical Journal , vol.25, no.1 , 49-55.

METE, A. Ö., VAHAPOĞLU, A., ERÖZCAN, T. O., KOÇAK, K., SARIGÜL, F., ZEKA, A. N., ... DORA, D. D.(2024). Safety Evaluation and Tolerability Overview of Favipiravir in the Management of COVID-19: A Real-Life Experience from Turkey. İstanbul Medical Journal , vol.25, no.1, 49-55.

METE, Ayşe Et Al. "Safety Evaluation and Tolerability Overview of Favipiravir in the Management of COVID-19: A Real-Life Experience from Turkey," İstanbul Medical Journal , vol.25, no.1, 49-55, 2024

METE, Ayşe Ö. Et Al. "Safety Evaluation and Tolerability Overview of Favipiravir in the Management of COVID-19: A Real-Life Experience from Turkey." İstanbul Medical Journal , vol.25, no.1, pp.49-55, 2024

METE, A. Ö. Et Al. (2024) . "Safety Evaluation and Tolerability Overview of Favipiravir in the Management of COVID-19: A Real-Life Experience from Turkey." İstanbul Medical Journal , vol.25, no.1, pp.49-55.

@article{article, author={Ayşe Özlem METE Et Al. }, title={Safety Evaluation and Tolerability Overview of Favipiravir in the Management of COVID-19: A Real-Life Experience from Turkey}, journal={İstanbul Medical Journal}, year=2024, pages={49-55} }